{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,6]],"date-time":"2026-04-06T14:03:06Z","timestamp":1775484186410,"version":"3.50.1"},"reference-count":37,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["ard.eular.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of the Rheumatic Diseases"],"published-print":{"date-parts":[[2020,7]]},"DOI":"10.1136\/annrheumdis-2020-217871","type":"journal-article","created":{"date-parts":[[2020,5,29]],"date-time":"2020-05-29T22:38:20Z","timestamp":1590791900000},"page":"859-866","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":933,"title":["Characteristics associated with hospitalisation for COVID-19 in people with rheumatic disease: data from the COVID-19 Global Rheumatology Alliance physician-reported registry"],"prefix":"10.1016","volume":"79","author":[{"given":"Milena","family":"Gianfrancesco","sequence":"first","affiliation":[]},{"given":"Kimme L","family":"Hyrich","sequence":"additional","affiliation":[]},{"given":"Sarah","family":"Al-Adely","sequence":"additional","affiliation":[]},{"given":"Loreto","family":"Carmona","sequence":"additional","affiliation":[]},{"given":"Maria I","family":"Danila","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4528-310X","authenticated-orcid":false,"given":"Laure","family":"Gossec","sequence":"additional","affiliation":[]},{"given":"Zara","family":"Izadi","sequence":"additional","affiliation":[]},{"given":"Lindsay","family":"Jacobsohn","sequence":"additional","affiliation":[]},{"given":"Patricia","family":"Katz","sequence":"additional","affiliation":[]},{"given":"Saskia","family":"Lawson-Tovey","sequence":"additional","affiliation":[]},{"given":"Elsa F","family":"Mateus","sequence":"additional","affiliation":[]},{"given":"Stephanie","family":"Rush","sequence":"additional","affiliation":[]},{"given":"Gabriela","family":"Schmajuk","sequence":"additional","affiliation":[]},{"given":"Julia","family":"Simard","sequence":"additional","affiliation":[]},{"given":"Anja","family":"Strangfeld","sequence":"additional","affiliation":[]},{"given":"Laura","family":"Trupin","sequence":"additional","affiliation":[]},{"given":"Katherine D","family":"Wysham","sequence":"additional","affiliation":[]},{"given":"Suleman","family":"Bhana","sequence":"additional","affiliation":[]},{"given":"Wendy","family":"Costello","sequence":"additional","affiliation":[]},{"given":"Rebecca","family":"Grainger","sequence":"additional","affiliation":[]},{"given":"Jonathan S","family":"Hausmann","sequence":"additional","affiliation":[]},{"given":"Jean W","family":"Liew","sequence":"additional","affiliation":[]},{"given":"Emily","family":"Sirotich","sequence":"additional","affiliation":[]},{"given":"Paul","family":"Sufka","sequence":"additional","affiliation":[]},{"given":"Zachary S","family":"Wallace","sequence":"additional","affiliation":[]},{"given":"Jinoos","family":"Yazdany","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8411-7972","authenticated-orcid":false,"given":"Pedro M","family":"Machado","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3156-3418","authenticated-orcid":false,"given":"Philip C","family":"Robinson","sequence":"additional","affiliation":[]}],"member":"78","reference":[{"key":"10.1136\/annrheumdis-2020-217871_bib1","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1093\/rheumatology\/kes305","article-title":"The risk of infections associated with rheumatoid arthritis, with its comorbidity and treatment","volume":"52","author":"Listing","year":"2013","journal-title":"Rheumatology"},{"key":"10.1136\/annrheumdis-2020-217871_bib2","doi-asserted-by":"crossref","unstructured":"Kim AHJ, Sparks JA, Liew JW, et al. A rush to judgment? rapid reporting and dissemination of results and its consequences regarding the use of hydroxychloroquine for COVID-19. Ann Intern Med 2020. doi:10.7326\/M20-1223","DOI":"10.7326\/M20-1223"},{"key":"10.1136\/annrheumdis-2020-217871_bib3","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1016\/S0140-6736(20)30628-0","article-title":"COVID-19: consider cytokine storm syndromes and immunosuppression","volume":"395","author":"Mehta","year":"2020","journal-title":"Lancet"},{"key":"10.1136\/annrheumdis-2020-217871_bib4","doi-asserted-by":"crossref","unstructured":"Konig MF, Kim AHJ, Scheetz MH, et al. Baseline use of hydroxychloroquine in systemic lupus erythematosus does not preclude SARS-CoV-2 infection and severe COVID-19. Ann Rheum Dis 2020. doi: 10.1136\/annrheumdis-2020-217690. %5BEpub ahead of print 7 May 2020%5D.","DOI":"10.1136\/annrheumdis-2020-217690"},{"key":"10.1136\/annrheumdis-2020-217871_bib5","doi-asserted-by":"crossref","unstructured":"Robinson PC, Yazdany J. The COVID-19 global rheumatology alliance: collecting data in a pandemic. Nat Rev Rheumatol;39. doi:10.1038\/s41584-020-0418-0","DOI":"10.1038\/s41584-020-0418-0"},{"key":"10.1136\/annrheumdis-2020-217871_bib6","doi-asserted-by":"crossref","unstructured":"Wallace ZS, Bhana S, Hausmann JS, et al. The rheumatology community responds to the COVID-19 pandemic: the establishment of the COVID-19 global rheumatology alliance. Rheumatology 2020. doi: doi:10.1093\/rheumatology\/keaa191. [Epub ahead of print: 06 May 2020].http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/32374851","DOI":"10.1093\/rheumatology\/keaa191"},{"key":"10.1136\/annrheumdis-2020-217871_bib7","doi-asserted-by":"crossref","unstructured":"Gianfrancesco M, Hyrich KL, Gossec L, et al. Rheumatic disease and COVID-19: initial data from the COVID-19 global rheumatology alliance provider registry. Lancet Rheumatol 2020.","DOI":"10.1016\/S2665-9913(20)30095-3"},{"key":"10.1136\/annrheumdis-2020-217871_bib8","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1136\/annrheumdis-2020-217566","article-title":"Clinical course of coronavirus disease 2019 (COVID-19) in a series of 17 patients with systemic lupus erythematosus under long-term treatment with hydroxychloroquine","volume":"79","author":"Mathian","year":"2020","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/annrheumdis-2020-217871_bib9","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1136\/annrheumdis-2020-217424","article-title":"Clinical course of COVID-19 in a series of patients with chronic arthritis treated with immunosuppressive targeted therapies","volume":"79","author":"Monti","year":"2020","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/annrheumdis-2020-217871_bib10","doi-asserted-by":"crossref","unstructured":"Favalli EG, Ingegnoli F, Cimaz R, et al. What is the true incidence of COVID-19 in patients with rheumatic diseases? Ann Rheum Dis 2020. doi: doi:10.1136\/annrheumdis-2020-217615. [Epub ahead of print: 22 Apr 2020].http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/32321723","DOI":"10.1136\/annrheumdis-2020-217615"},{"key":"10.1136\/annrheumdis-2020-217871_bib11","doi-asserted-by":"crossref","unstructured":"Favalli EG, Agape E, Caporali R. Incidence and clinical course of COVID-19 in patients with connective tissue diseases: a descriptive observational analysis. J Rheumatol 2020. doi: doi:10.3899\/jrheum.200507. [Epub ahead of print: 25 Apr 2020].http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/32335513","DOI":"10.3899\/jrheum.200507"},{"key":"10.1136\/annrheumdis-2020-217871_bib12","doi-asserted-by":"crossref","unstructured":"Arentz M, Yim E, Klaff L, et al. Characteristics and outcomes of 21 critically ill patients with COVID-19 in Washington state. JAMA 2020. doi: doi:10.1001\/jama.2020.4326. [Epub ahead of print: 19 Mar 2020].http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/32191259","DOI":"10.1001\/jama.2020.4326"},{"key":"10.1136\/annrheumdis-2020-217871_bib13","doi-asserted-by":"crossref","unstructured":"Chen T, Wu D, Chen H, et al. Clinical characteristics of 113 deceased patients with coronavirus disease 2019: retrospective study. BMJ:m1091. doi:10.1136\/bmj.m1091","DOI":"10.1136\/bmj.m1091"},{"key":"10.1136\/annrheumdis-2020-217871_bib14","doi-asserted-by":"crossref","unstructured":"Huang C, Wang Y, Li X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 2020.","DOI":"10.1016\/S0140-6736(20)30183-5"},{"key":"10.1136\/annrheumdis-2020-217871_bib15","doi-asserted-by":"crossref","unstructured":"Wu Z, McGoogan JM. Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72 314 cases from the Chinese center for disease control and prevention. JAMA 2020.","DOI":"10.1001\/jama.2020.2648"},{"key":"10.1136\/annrheumdis-2020-217871_bib16","unstructured":"Guan WJ, ZY N, Hu Y, et al. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med 2020."},{"key":"10.1136\/annrheumdis-2020-217871_bib17","unstructured":"Grasselli G, Zangrillo A, Zanella A, et al. Baseline characteristics and outcomes of 1591 patients infected with SARS-CoV-2 admitted to ICUs of the Lombardy region, Italy. JAMA 2020. doi: doi:10.1001\/jama.2020.5394. [Epub ahead of print: 06 Apr 2020].http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/32250385"},{"key":"10.1136\/annrheumdis-2020-217871_bib18","doi-asserted-by":"crossref","unstructured":"Goyal P, Choi JJ, Pinheiro LC, et al. Clinical characteristics of Covid-19 in New York City. N Engl J Med Overseas Ed. doi:10.1056\/NEJMc2010419","DOI":"10.1056\/NEJMc2010419"},{"key":"10.1136\/annrheumdis-2020-217871_bib19","unstructured":"Richardson S, Hirsch JS, Narasimhan M, et al. Presenting characteristics, comorbidities, and outcomes among 5700 patients hospitalized with COVID-19 in the new York City area. JAMA 2020. doi: doi:10.1001\/jama.2020.6775. [Epub ahead of print: 22 Apr 2020].http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/32320003"},{"key":"10.1136\/annrheumdis-2020-217871_bib20","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1007\/s00134-020-05991-x","article-title":"Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China","volume":"46","author":"Ruan","year":"2020","journal-title":"Intensive Care Med"},{"key":"10.1136\/annrheumdis-2020-217871_bib21","doi-asserted-by":"crossref","first-page":"1914","DOI":"10.1136\/ard.2011.151043","article-title":"Treatment benefit or survival of the fittest: what drives the time-dependent decrease in serious infection rates under TNF inhibition and what does this imply for the individual patient?","volume":"70","author":"Strangfeld","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/annrheumdis-2020-217871_bib22","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1136\/annrheumdis-2020-217480","article-title":"Festina lente: hydroxychloroquine, COVID-19 and the role of the rheumatologist","volume":"79","author":"Graef","year":"2020","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/annrheumdis-2020-217871_bib23","doi-asserted-by":"crossref","unstructured":"Gautret P, Lagier J-C, Parola P, et al. Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial. Int J Antimicrob Agents 2020:105949. doi:10.1016\/j.ijantimicag.2020.105949, http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/32205204","DOI":"10.1016\/j.ijantimicag.2020.105949"},{"key":"10.1136\/annrheumdis-2020-217871_bib24","doi-asserted-by":"crossref","unstructured":"Gautret P, Lagier JC, Parola P, et al. Clinical and microbiological effect of a combination of hydroxychloroquine and azithromycin in 80 COVID-19 patients with at least a six-day follow up: an observational study. Travel Med Infect Dis 2020.","DOI":"10.1016\/j.tmaid.2020.101663"},{"key":"10.1136\/annrheumdis-2020-217871_bib25","unstructured":"Chen J, Liu D, Liu L, et al. A pilot study of hydroxychloroquine in treatment of patients with common coronavirus disease-19 (COVID-19). Journal of Zhejiang University 2020."},{"key":"10.1136\/annrheumdis-2020-217871_bib26","doi-asserted-by":"crossref","unstructured":"Chen Z, Hu J, Zhang Z, et al. Efficacy of hydroxychloroquine in patients with COVID-19: results of a randomized clinical trial. MedRxiv 2020.","DOI":"10.1101\/2020.03.22.20040758"},{"key":"10.1136\/annrheumdis-2020-217871_bib27","unstructured":"Borba MG, Val FF, Sampaio VS, et al. Chloroquine diphosphate in two different dosages as adjunctive therapy of hospitalized patients with severe respiratory syndrome in the context of coronavirus (SARS-CoV-2) infection: preliminary safety results of a randomized, double-blinded, phase IIb clinical trial (CloroCovid-19 study). MedRxiv 2020."},{"key":"10.1136\/annrheumdis-2020-217871_bib28","unstructured":"Mahevas M, Tran VT, Roumier M, et al. No evidence of clinical efficacy of hydroxychloroquine in patients hospitalized for COVID-19 infection with oxygen requirement: results of a study using routinely collected data to emulate a target trial. medRxiv 2020."},{"key":"10.1136\/annrheumdis-2020-217871_bib29","doi-asserted-by":"crossref","unstructured":"Magagnoli J, Narendran S, Pereira F, et al. Outcomes of hydroxychloroquine usage in United States veterans hospitalized with Covid-19. medRxiv 2020.","DOI":"10.1101\/2020.04.16.20065920"},{"key":"10.1136\/annrheumdis-2020-217871_bib30","doi-asserted-by":"crossref","first-page":"m1168","DOI":"10.1136\/bmj.m1168","article-title":"Covid-19: European drugs agency to review safety of ibuprofen","volume":"368","author":"Day","year":"2020","journal-title":"BMJ"},{"key":"10.1136\/annrheumdis-2020-217871_bib31","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/S0140-6736(20)30183-5","article-title":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China","volume":"395","author":"Huang","year":"2020","journal-title":"Lancet"},{"key":"10.1136\/annrheumdis-2020-217871_bib32","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1016\/S0140-6736(20)30566-3","article-title":"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study","volume":"395","author":"Zhou","year":"2020","journal-title":"Lancet"},{"key":"10.1136\/annrheumdis-2020-217871_bib33","first-page":"v1","article-title":"Effective treatment of severe COVID-19 patients with tocilizumab","volume":"00026","author":"Xu","year":"2020","journal-title":"ChinaXiv"},{"key":"10.1136\/annrheumdis-2020-217871_bib34","article-title":"Tocilizumab treatment in COVID-19: a single center experience","volume":"8","author":"Luo","year":"2020","journal-title":"J Med Virol"},{"key":"10.1136\/annrheumdis-2020-217871_bib35","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1016\/S0140-6736(20)30858-8","article-title":"Trials of anti-tumour necrosis factor therapy for COVID-19 are urgently needed","volume":"395","author":"Feldmann","year":"2020","journal-title":"The Lancet"},{"key":"10.1136\/annrheumdis-2020-217871_bib36","doi-asserted-by":"crossref","unstructured":"Mikuls TR, Johnson SR, Fraenkel L, et al. American College of rheumatology guidance for the management of adult patients with rheumatic disease during the COVID-19 pandemic. Arthritis Rheumatol 2020. doi: doi:10.1002\/art.41301. [Epub ahead of print: 29 Apr 2020].http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/32349183","DOI":"10.1002\/art.41301"},{"key":"10.1136\/annrheumdis-2020-217871_bib37","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1136\/annrheumdis-2020-217877","article-title":"EULAR provisional recommendations for the management of rheumatic and musculoskeletal diseases in the context of SARS-CoV-2","volume":"79","author":"Landew\u00e9","year":"2020","journal-title":"Ann Rheum Dis"}],"container-title":["Annals of the Rheumatic Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003496724013190?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003496724013190?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/annrheumdis-2020-217871","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,5]],"date-time":"2025-01-05T06:44:49Z","timestamp":1736059489000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0003496724013190"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7]]},"references-count":37,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2020,7]]}},"alternative-id":["S0003496724013190"],"URL":"https:\/\/doi.org\/10.1136\/annrheumdis-2020-217871","relation":{},"ISSN":["0003-4967"],"issn-type":[{"value":"0003-4967","type":"print"}],"subject":[],"published":{"date-parts":[[2020,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Characteristics associated with hospitalisation for COVID-19 in people with rheumatic disease: data from the COVID-19 Global Rheumatology Alliance physician-reported registry","name":"articletitle","label":"Article Title"},{"value":"Annals of the Rheumatic Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1136\/annrheumdis-2020-217871","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2020 \u00a9 Author(s) (or their employer(s)) 2020. No commercial re-use. See rights and permissions. Published by Elsevier Inc. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}